Expertise in professional pharmaceutical project management
Active Awarded Last action
- Contract number
- 75N93024F00003
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $693,109
Award facts
- Contract value 11% obligated
-
- $693,109.00 Current, with exercised options
- $6,095,159.00 Potential, with all options
- Completion date 39% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
This is a $6,095,159.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL) for expertise in professional pharmaceutical project management. The contract is issued under the larger Resources to Advance Pediatrics and HIV Prevention Science indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. ABL, a manufacturer of biologics including vaccines and monoclonal antibodies, will provide a range of services to support NIAID's infectious disease research and product development initiatives, such as biologics manufacturing, testing, quality assurance, data management, and project management. The contract does not have a set-aside designation. ABL has also been awarded federal grants, primarily from NIAID, to develop new vaccines and support NIH's broader vaccine and therapeutic development programs.
Quick answers
Who was awarded contract 75N93024F00003?
75N93024F00003 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 1, 2024.
How much is contract 75N93024F00003 worth?
The government has obligated $693,109 on 75N93024F00003. Its potential value, with all options, is $6,095,159.
Is contract 75N93024F00003 an order under another contract?
Yes. 75N93024F00003 is a delivery order under 75N93023D00001, an indefinite delivery contract, on Resources to Advance Pediatrics and HIV Prevention Science.
Was contract 75N93024F00003 competed?
The extent of competition for 75N93024F00003 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award